Author

A. W. Craig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1

Frequent Co-Authors

S. Young· 2 shared A. Garven· 1 shared A. L. Simpson· 1 shared B. J. Laight· 1 shared C. Graham· 1 shared C. Hedrich· 1 shared C. Shi· 1 shared C. Vlasschaert· 1 shared

Activity by Year

2018-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Young

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Fes-deficient macrophages enhance CD8+ T cell priming and tumour control through increased proinflammatory cytokine production and localization

B. J. Laight, D. Harper, N. Dmytryk, S. Zhang, A. Garven, C. Shi, R. Nauman, J. Kment, F. Alotaibi, I. Shapovalov, Y. Gao, J. Mewburn, C. Vlasschaert, D. LeBrun, K. Tyryshkin, , P. A. Greer

bioRxiv · Feb 27, 2024 · PreprintImmunology

Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes

P. Truesdell, J. Chang, D. Coto Villa, Y. Zhao, R. McIlwain, S. Young, S. Hiley, A. W. Craig, T. Babak

The paper identifies pharmacogenomic screening principles that predict clinical efficacy in cancer patients with specific driver mutations.

bioRxiv · Jan 5, 2024Cancer Biology

Aberrant mast cell activation promotes chronic recurrent multifocal osteomyelitis

S. Young, N. Sharma, J. H. P. Lee, V. Chitu, V. Neumeister, E. Sohr, R. Stanley, C. Hedrich, A. W. Craig

This study identifies mast cells as contributors to bone inflammation in CMO/CRMO by showing their accumulation in inflamed tissues and elevated mast cell markers in CRMO patients.

bioRxiv · Oct 12, 2018Immunology